Have Gilead's Gains Evaporated in the Coronavirus Treatment Race?

Retrieved on: 2020-11-28 12:11:15

Tags for this article:

Health sciences

Life Sciences

Health

Antivirals

COVID-19 drug development

Pharmaceutical industry

Filgotinib

Click the tags to see associated articles and topics

Have Gilead's Gains Evaporated in the Coronavirus Treatment Race?. View article details on hiswai:

Excerpt

The company's antiviral drug, <b>remdesivir</b>, emerged as a potential treatment for COVID-19 in the early days of the outbreak. As a result, while the rest of ...

Article found on: www.fool.com

View Original Article